Study on the stability of deoxyarbutin in an anhydrous emulsion system

International Journal of Molecular Sciences

Volumn 12, Issue 9, 2011, Pages 5946-5954

  Lin, Chih Chien ^a   Yang, Chao Hsun ^a   Chang, Nai Fang ^a   Wu, Pey Shiuan ^a   Chen, Yi Shyan ^a   Lee, Shu Mei ^b   Chen, Chiu Wen ^a  

^a PROVIDENCE UNIVERSITY   (Taiwan)

^b Nursing and Management ollege ^*  (Taiwan)

Author keywords

Anhydrous emulsion system; Deoxyarbutin; Hydroquinone; Skin hitening; Stability

Indexed keywords

DEOXYARBUTIN; DERMATOLOGICAL AGENT; GLYCEROL; HYDROQUINONE; POLYOL; PROPYLENE GLYCOL; SILICONE; UNCLASSIFIED DRUG; ARBUTIN; EMULSION; HYDROQUINONE DERIVATIVE; OIL; POLYMER; SILICON; WATER;

ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG DECOMPOSITION; DRUG DETERMINATION; DRUG FORMULATION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; EMULSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; TEMPERATURE SENSITIVITY; ANALOGS AND DERIVATIVES; CHEMISTRY; HYDROLYSIS; TEMPERATURE;

ARBUTIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; EMULSIONS; HYDROLYSIS; HYDROQUINONES; OILS; POLYMERS; SILICON; TEMPERATURE; WATER;

EID: 80053191843     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12095946     Document Type: Article

References (18)

1. Huang, H.C.; Chiu, S.H.; Chang, T.M. Inhibitory effect of [6]-GINGEROL ON MELANOgenesis in B16F10 melanoma cells and a possible mechanism of action. Biosci. Biotechnol. Biochem. 2011, 75, 1067-1072
2. Kubo, I.; Nitoda, T.; Nihei, K. Effects of quercetin on mushroom tyrosinase and B16-F10 melanoma cells. Molecules 2007, 12, 1045-1056
3. Chang, T.S. An updated review of tyrosinase inhibitors. Int. J. Mol. Sci. 2009, 10, 2440-2475
4. Fais, A.; Corda, M.; Era, B.; Fadda, M.B.; Matos, M.J.; Quezada, E.; Santana, L.; Picciau, C.; Podda, G.; Delogu, G. Tyrosinase inhibitor activity of coumarin-resveratrol hybrids. Molecules 2009, 14, 2514-2520
5. Dawley, R.M.; Flurkey, W.H. 4-hexylresorcinol, a potent inhibitor of mushroom tyrosinase. J. Food Sci. 1993, 58, 609-610
6. Sato, K.; Toriyama, M. Depigmenting effect of catechins. Molecules 2009, 14, 4425-4432
7. Tai, S.S.; Lin, C.G.; Wu, M.H.; Chang, T.S. Evaluation of depigmenting activity by 8-hydroxydaidzein in mouse B16 melanoma cells and human volunteers. Int. J. Mol. Sci. 2009, 10, 4257-4266
8. Hamed, S.H.; Sriwiiyanont, P.; Wickett, R.R.; Boissy, R. Effect of deoxyarbutin on melanogenesis: In vivo comparison with other melanogenesis inhibitor. J. Cosmet. Sci. 2004, 55, 118-119
9. Boissy, R.E.; Visscher, M.; DeLong, M.A. DeoxyArbutin: A novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp. Dermatol. 2005, 14, 601-608
10. Chawla, S.; de Long, M.A.; Visscher, M.O.; Wickett, R.R.; Manga, P.; Boissy, R.E. Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives. Br. J. Dermatol. 2008, 159, 1267-1274
11. Yang, C.-H.; Chen, Y.-S.; Lai, J.-S.; Hong, W.W.L.; Lin, C.-C. Determination of the thermodegradation of deoxyArbutin in aqueous solution by high performance liquid chromatography. Int. J. Mol. Sci. 2010, 11, 3977-3987
12. Suitthimeathegorn, O.; Jaitely, V.; Florence, A.T. Novel anhydrous emulsions: Formulation as controlled release vehicles. Int. J. Pharm. 2005, 298, 367-371
13. Wang, T.; Wang, N.; Hao, A.; He, X.; Li, T.; Deng, Y. Lyophilization of water-in-oil emulsions to prepare phospholipid-based anhydrous reverse micelles for oral peptide delivery. Eur. J. Pharm. Sci. 2010, 39, 373-379
14. Cameron, N.R.; Sherrington, D.C. Non-aqueous high internal phase emulsions. Preparation and stability. J. Chem. Soc. Faraday Trans. 1996, 92, 1543-1547
15. Sakthivel, T.; Jaitely, V.; Patel, N.V.; Florence, A.T. Non-aqueous emulsions: Hydrocarbonformamide systems. Int. J. Pharm. 2001, 214, 43-48
16. Shibata, H.; Nakagawa, S.; Tsutsumi, Y. Optimization of protein therapies by polymer-conjugation as an effective DDS. Molecules 2005, 10, 162-180
17. Chae, G.S.; Lee, J.S.; Kim, S.H.; Seo, K.S.; Kim, M.S.; Lee, H.B.; Khang, G. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer. Int. J. Pharm. 2005, 301, 6-14
18. Heiati, H.; Tawashi, R.; Phillips, N.C. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. J. Microencapsul. 1998, 15, 173-184.